Prognostic Factors Associated with Acute Heart Failure in Patients Admitted for COVID-19: Analysis of the SEMI-COVID-19 Registry
暂无分享,去创建一个
R. Gómez Huelgas | M. Méndez Bailón | J. Ramos-Rincón | A. Artero | N. Lorenzo Villalba | J. N. Alcalá Pedrajas | On Behalf Of The Semi-Covid-Network | M. Rubio Rivas | E. F. Fonseca Aizpuru | M. García Gómez | C. Martínez Cilleros | J. Escobar Sevilla | M. V. Villalba García | G. M. García García | Raquel Gómez Méndez | Daniel Monge Monge | V. Giner Galvañ | E. Montero Hernández | C. Díaz Pedroche | Laura Letona Giménez | P. M. Pesqueira Fontán | N. Puente Ruiz | María de los Reyes Pascual Pérez | Jorge Garcia Onrubia | M. Núñez Rodríguez | Gema María García García | J. Ramos-Rincón | María de Los Reyes Pascual Pérez | Vicente Giner Galvañ
[1] E. Tsai,et al. Cell-Specific Mechanisms in the Heart of COVID-19 Patients , 2023, Circulation research.
[2] Qi Liu,et al. Effect of continuing the use of renin–angiotensin system inhibitors on mortality in patients hospitalized for coronavirus disease 2019: a systematic review, meta-analysis, and meta-regression analysis , 2023, BMC Infectious Diseases.
[3] Jinkwon Kim,et al. Association of atrial fibrillation with infectivity and severe complications of COVID‐19: A nationwide cohort study , 2022, Journal of medical virology.
[4] D. Morrow,et al. Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials Network , 2022, Journal of Cardiac Failure.
[5] Le Huu Nhat Minh,et al. COVID-19 and arrhythmia: An overview , 2021, Journal of Cardiology.
[6] S. Basili,et al. Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis , 2021, Scientific Reports.
[7] R. Gómez-Huelgas,et al. [Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain]. , 2021, Revista clinica espanola.
[8] G. Lip,et al. Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis , 2021, Journal of clinical medicine.
[9] O. Werz,et al. SARS-CoV-2 Causes Severe Epithelial Inflammation and Barrier Dysfunction , 2021, Journal of Virology.
[10] Z. Şi̇mşek,et al. New onset atrial fibrilation and risk faktors in COVID-19 , 2021, Journal of Electrocardiology.
[11] T. Hinks,et al. Azithromycin in viral infections , 2020, Reviews in medical virology.
[12] A. Borobia,et al. Heart failure in COVID‐19 patients: prevalence, incidence and prognostic implications , 2020, European journal of heart failure.
[13] C. Tascini,et al. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key? , 2020, Frontiers in Immunology.
[14] R. Starling,et al. Heart failure and COVID-19 , 2020, Heart Failure Reviews.
[15] J. Ramos-Rincón,et al. Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry , 2020, Revista Clínica Española (English Edition).
[16] Irfan Ahmed Rind,et al. The impact of COVID‐19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic , 2020, European journal of heart failure.
[17] S. Solomon,et al. COVID‐19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease , 2020, European journal of heart failure.
[18] D. Raoult,et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial , 2020, International Journal of Antimicrobial Agents.
[19] Sharukh Lokhandwala,et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. , 2020, JAMA.
[20] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[21] Marco Falcone,et al. Cardiovascular Complications and Short-term Mortality Risk in Community-Acquired Pneumonia , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] Héctor Bueno,et al. Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica , 2016 .
[23] P. Seferovic,et al. Heart Failure in Patients with Diabetes Mellitus. , 2016, Cardiac failure review.
[24] J. Penninger,et al. SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS , 2009, European journal of clinical investigation.
[25] V. Zarubaev,et al. Clinical Research , 2022 .
[26] S. Yiu,et al. Left Ventricular Performance in Patients With Severe Acute Respiratory Syndrome: A 30-Day Echocardiographic Follow-Up Study , 2003, Circulation.
[27] Douglas W Mahoney,et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.
[28] G. Fonarow,et al. Epidemiology and risk profile of heart failure , 2011, Nature Reviews Cardiology.